UNSPSC 51343702: Moroxydine

This classification denotes an anti-infective agent with the molecular formula C6H13N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O611591WAH, chemically known as 4-morpholinecarboximidamide, n- (aminoiminomethyl)-, monohydrochloride but generally known as moroxydine, which bears US NIH Compound Identifier 71655. European Medicines Agency schedules Moroxydine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09070MIG.

UNSPSC 51343702 Moroxydine is a Commodity code that nominally covers a single pharmaceutical ingredient, but recent state and local solicitations show little activity directly aligned with that category. The code appears in procurement records alongside broader pharmaceutical and medical supply opportunities, though the specific purchase of moroxydine as a standalone product line does not feature prominently in current state and local contract activity. State and local governments are instead soliciting medical and emergency-response supplies, naloxone products, generic pharmaceuticals, and over-the-counter medicines through cooperative purchasing vehicles and direct competitive bids. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire and rescue departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota, Oregon, and other participating states).

Recent opportunities posted under or near this code reflect procurement of medical supplies and pharmaceuticals rather than moroxydine specifically. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with responses due July 26, 2023, for quarterly delivery to the Seminole County Community Health Building. The City of Tampa released IFB 26P00145 in March 2026 for medical and first aid supplies (169 line items including respiratory equipment, cardiac monitoring electrodes, and consumables) for the Tampa Fire Department Rescue Division, with a one-year award and two one-year renewal options; this procurement was sheltered for certified Small Local Business Enterprises with an estimated contract value of $700,000. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) due March 26, 2026, for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, effective July 1, 2026. The code shows limited direct activity for moroxydine procurement; business development focus should track broader medical supply and pharmaceutical cooperative purchasing vehicles where demand is demonstrable.